NSEGeneral Updates30 Jun 2026 · 30 Jun 2026, 12:05 pm
General Updates
Lyka Labs Limited · LYKALABS
✦ AI SummaryRelated Party
Lyka Labs Limited has received disclosures from its promoter, Kunal N. Gandhi, regarding the acquisition of 14176 equity shares through open market purchases.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lyka Labs Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
LYKALABS_30062026120505_Signed_Intimation_to_Stock_Exchanges_of_PIT.pdf
View document text
30th June, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra Kurla Complex, Bandra (East),
Mumbai 400 001 Mumbai 400 051
Scrip Code: 500259 Scrip Code: LYKALABS
Sub.: Disclosure under Regulation 7(2) read with Regulation 6(2) – Continual
Disclosure of SEBI (Prohibition of Insider Trading) Regulations, 2015
Dear Sir/Madam,
Please note that the Company has received disclosures from Mr. Kunal N. Gandhi, Promoter
of the Company under Regulation 7(2)(a) read with Regulation 6(2) of SEBI PIT
Regulations.2015 in respect of the acquisition of 14176 equity shares through open market.
Accordingly, please find enclosed the said disclosures and take the same on record in
compliance with the provisions of Regulation 7(2)(b) of the SEBI PIT Regulations.
Thanking you,
Yours faithfully,
For Lyka Labs Limited
Shailendra Kumar Agrawal
Company Secretary and Compliance Officer
Place: Mumbai
Kunal N. Gandhi
3C, Ridge Apt, B.G.Kher Marg, Malabar Hill, MUMBAI 400 006
29th June, 2026
The Compliance Officer
Lyka Labs Limited
Spencer Building, Ground Floor,
30 Forjett Street, Tardeo, Grant Road West,
Mumbai 400036
Sub: Disclosure under Regulation 7 (2) read with Regulation 6(2) Continual Disclosure
of SEBI (Prohibition of Insider Trading) Regulations, 2015
Dear Sir/Madam,
Sub: Disclosure under Regulation 7 (2) read with Regulation 6(2) Continual Disclosure
of SEBI (Prohibition of Insider Trading) Regulations, 2015
I, Mr. Kunal Gandhi, being a Promoter of Lyka Labs Limited, hereby inform you that I have
acquired an aggregate of 14176 equity shares of the Company through open market purchases
on 29th June, 2026.
Pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider
Trading) Regulations, 2015, please find enclosed Form C containing the requisite continual
disclosure in respect of the above acquisition.
You are requested to take note on record and forward the same to Both the Exchanges BSE
Limited and NSE Limited as per the requirement of SEBI(PIT) Regulation, 2015.
Thanking you,
Yours Faithfully,
(Kunal Gandhi)
Promoter
Encl.: Disclosure under 7(2) of SEBI PIT Regulations